Comparing cancer care in the United States and Europe reveals striking differences in approach . The US system, often characterized as fee-for-service , tends to emphasize cutting-edge innovations , frequently resulting in greater costs and variable access for care. Conversely, many European nations operate under publicly funded healthcare models,